CRANBURY, N.J.--(BUSINESS WIRE)--Feb. 16, 2006--Kos Pharmaceuticals, Inc. (Nasdaq:KOSP), a fully integrated specialty pharmaceutical company, will announce results for the fourth quarter and full year ended December 31, 2005, before the market opens on Thursday, February 23, 2006.
